• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. LEGION CR NP FEM SZ 4 RT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/LYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. LEGION CR NP FEM SZ 4 RT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/LYMER Back to Search Results
Model Number 71423214
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Anemia (1706); Constipation (3274)
Date of Event 11/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event or Problem Description
It was reported that, after a tka surgery performed on (b)(6) 2022, the patient experienced constipation and post-operative anemia.The anemia was treated with 1 unit of rbc and the constipation with docusate sodium 50 mg + sennoside b 8 mg tablet.The patient recovered.
 
Additional Manufacturer Narrative
Given the nature of the alleged incident, the devices were not returned for evaluation but the reported event could be confirmed with the clinical/medical findings.The clinical/medical investigation concluded that, per complaint details, the study patient experienced constipation and post-operative anemia after a right cori-assisted total knee arthroplasty and was treated with docusate/sennoside b and 1 unit of red blood cell (rbc).The provided electronic case report forms (ecrfs) documented the anticipated, mild, and serious adverse event (ae)(#1) was unrelated to the study device but possibly related to the study procedure and required in-patient or prolonged hospitalization with start date as (b)(6) 2022.The ae summary/ecrf showed patient developed abdominal pain and imaging showed fecal loading throughout the colon/gas in rectum with bid docusate/sennoside started on (b)(6) 2022 per the medication ecrf.The pre-op hgb was 12 per operative data and the 1 unit of rbc was administered several days following the procedure ((b)(6) 2022).The patient outcome/ae(#1) was documented as recovered/resolved with an end date of (b)(6) 2022.Post-operative blood loss anemia and constipation are known possible risks with any surgical procedure and are not indicative of a malperformance of the component(s).The patient impact was the reported constipation with pain, post-op anemia, medication and blood product administration, and in-patient or prolonged hospitalization.No further medical assessment is warranted at this time.A review of the production orders for legion cruciate retaining nonporous femoral size 4 right, legion cruciate retaining high flexion cross linked polyethylene size, genesis ii non-porous tibial baseplate size 3 right and genesis ii oval resurfacing patellar 32mm did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part numbers over the past 12 months and for the batch numbers based on historical data of each device did not reveal similar events for the listed devices.A review of the instructions for use documents for knee systems provides complete guidelines of indications, contraindications, warnings and precautions and possible adverse effects that may occur preoperative, during surgery or post operative.Post-operative blood loss anemia and constipation are known possible risks with any surgical procedure and are not indicative of a malperformance of the component(s).A review of the risk management file is not applicable because no information was provided that relates the failure mode to the devices.A historical review concluded that there are no prior actions related to these products and event.At this time, we have no reason to suspect that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include patient condition and/or medical history.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEGION CR NP FEM SZ 4 RT
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/LYMER
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16400982
Report Number1020279-2023-00365
Device Sequence Number14854265
Product Code JWH
UDI-Device Identifier00885556029930
UDI-Public00885556029930
Combination Product (Y/N)N
Initial Reporter CountryNZ
PMA/510(K) Number
K060742
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number71423214
Device Catalogue Number71423214
Device Lot Number21HM06443
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/24/2023
Supplement Date Received by Manufacturer04/05/2023
Initial Report FDA Received Date02/17/2023
Supplement Report FDA Received Date04/12/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/09/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PN: 71420182 / LOT: 21GB00677.; PN: 71421032 / LOT: 21GB01791.; PN: 71453183 / LOT: 21JM20508.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
Patient Weight88 KG
Patient RaceWhite
-
-